We are proud to announce that our CEO Ulla Grove Krogsgaard Thomsen has been nominated as Life science executive of the year.
Dr. Thomsen joined Novo Nordisk Pharmatech A/S 1 April 2021 as CEO. Since 2019 she has been a member of our Board of Directors and has a more than 24-year background at Novo Nordisk in various positions and lifelong experience in protein-based medicines.
One of the reasons for the nomination is that Dr. Thomsen appears with great authenticity in her persona and leadership and has managed to set clear directions, purposes, and priorities for her organizations.
You can read more about the nomination here (in Danish).
You can also get her view on how we work at Novo Nordisk Pharmatech in the video below.